Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cobalt Catalyzed Hydroboration. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111943967A reveals a cost-effective cobalt-catalyzed dehydroboration of olefins, offering high-purity alkenyl boronates for pharmaceutical intermediate manufacturing.
Patent CN121085948A reveals a cobalt-catalyzed route for alpha-alkenyl boron esters. This method offers high selectivity, mild conditions, and scalable purification for pharmaceutical intermediates.